(19)
(11) EP 1 809 632 A2

(12)

(88) Date of publication A3:
17.08.2006

(43) Date of publication:
25.07.2007 Bulletin 2007/30

(21) Application number: 05800579.4

(22) Date of filing: 17.10.2005
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61K 31/519(2006.01)
A61P 9/00(2006.01)
A61P 15/00(2006.01)
C07D 519/00(2006.01)
A61P 9/12(2006.01)
A61P 25/00(2006.01)
A61P 3/00(2006.01)
(86) International application number:
PCT/IB2005/003326
(87) International publication number:
WO 2006/046135 (04.05.2006 Gazette 2006/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 28.10.2004 US 622941 P

(71) Applicant: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventors:
  • ACKER, Brad Alan, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • HUGHES, Robert Owen, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • JACOBSEN, Eric John, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • LU, Hwang-Fun, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • ROGERS, Thomas Edward, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • TOLLEFSON, Michael Brent, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)
  • WALKER, John Keith, Pfizer Global R&D
    Chesterfield, MO 63017-1732 (US)

(74) Representative: Kingsbury, Oliver William et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich Kent CT13 9NJ
Sandwich Kent CT13 9NJ (GB)

   


(54) PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES USEFUL AS PDE-5 INHIBITORS